This third patent issuance relative to trabecular screws for all orthopedic fixation establishes Cutting Edge Spine as a provider of transformational fixation technology that is trabecular in nature.
Xtant acquired certain assets, including equipment and inventory, used in RTI’s synthetic bone graft business and assumed the lease for the nanOss production facility.
The partnership aims to include Aclarion’s Nociscan surgical decisioning technology within ATEC’s AlphaInformatiX platform to better inform spine surgery.
OsteoSPAN Fiber Matrix is engineered for optimized handling, while providing verified osteoinductive potential and an osteoconductive scaffold to support cellular bone formation and stimulate fusion.
The study demonstrates positive, long-term clinical outcomes, a high rate of overall composite success at 60 months and statistical superiority to ACDF.